GALFER Capsule Ref.[49965] Active ingredients: Ferrous fumarate

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2019  Publisher: Thornton & Ross Limited, Linthwaite, Huddersfield, West Yorkshire, HD7 5QH, United Kingdom

Product name and form

Galfer Capsules.

Pharmaceutical Form

Capsule.

Qualitative and quantitative composition

Ferrous Fumarate BP 305.0mg (equivalent to 100mg elemental iron).

Active Ingredient Description
Ferrous fumarate

Ferrous fumarate is an easily absorbed source of iron for replacement therapy. It is a salt of ferrous iron with an organic acid and is less irritant to the gastro-intestinal tract than salts with inorganic acids. Iron and iron salts should be given for the treatment or prophylaxis of iron deficiency anaemias.

List of Excipients

Microcrystalline cellulose

Capsule shell ingredients:

Quinoline yellow (E104)
Indigotine (E132) Pharm Fr
Titanium dioxide (E171) Pharm Fr
Erythrosine (E127) Pharm Fr
Gelatin Ph Eur

Pack sizes and marketing

Cylindrical polypropylene containers with polyethylene snap-close caps.

Pack sizes: 100 and 250 capsules.

Child resistant vial complying with British Standard (BSI 5321).

Pack size: 30 capsules.

PVdC – Aluminium foil blisters.

Pack size: 28 capsules.

Marketing authorization holder

Thornton & Ross Limited, Linthwaite, Huddersfield, West Yorkshire, HD7 5QH, United Kingdom

Marketing authorization dates and numbers

PL 00240/0104

31 May 2003

Drugs

Drug Countries
GALFER Ireland, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.